Successful early outcomes for Vertera Spine's COHERE fusion device: 5 insights

Spinal Tech

Vertera Spine reported positive early outcomes for the COHERE Cervical Interbody Fusion Device.

Here are five insights:

 

1. COHERE includes patented porous PEEK Scoria biomaterial technology, which offers an environment for bone tissue ingrowth.

 

2. Vertera executed an initial soft launch of COHERE in May 2016. Since then, surgeons have implanted more than 400 COHERE devices during anterior cervical fusion surgeries.

 

3. COHERE represents the first device in clinical use to be made out of PEEK and have porosity.

 

4. The surgeons who implanted COHERE after the soft launch, are observing patients with early fusion signs with significant body bridging.

 

5. Vertera will feature the device at the North American Spine Society meeting in Boston from Oct. 25 to Oct. 28.

 

"Porous PEEK Scoria is a game-changing technology that will make all other PEEK devices obsolete and could lend itself to many future applications," said Brandon Strenge, MD, of Orthopaedic Institute in Paducah, Ky.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers